Vertaling van "inherent in research and development " (Frans → Nederlands) :

Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.
This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.

This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13, including its potential benefits; and the success of the AMC project for vaccines. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.

Pfizer Biotherapeutics et Pharmatherapeutics Research & Development possède cinq sites majeurs – quatre aux Etats-Unis et un en Grande-Bretagne.
Pfizer Biotherapeutics en Pfizer Pharmatherapeutics Research & Development telt vijf belangrijke vestigingen, vier in de Verenigde Staten en één in Engeland.

Le centre de recherche et de développement pionnier de Groton fait du Connecticut le cœur de Pfizer Biotherapeutics et Pharmatherapeutics Research & Development.
Pfizers toonaangevende onderzoeks- en ontwikkelingscentra in Groton maken Connecticut tot de hoofdvestiging van Pfizer Research & Development.

Le siège européen de Pfizer Biotherapeutics et Pharmatherapeutics Research & Development , situé à Sandwich, en Grande-Bretagne, joue un rôle prépondérant dans le développement de nouveaux médicaments Pfizer.
De Europese hoofdvestiging van Biotherapeutics en Pharmatherapeutics Research & Development in het Engelse Sandwich speelt een belangrijke rol in de ontwikkeling van nieuwe Pfizer-geneesmiddelen.

C’est en ces termes que le Dr. Martin Mackay, senior vice president Research & Technology chez Pfizer Global Research & Development, a présenté une initiative de coopération avec l’Organisation mondiale de la Santé.
Zo introduceerde Dr. Martin Mackay, senior vice president of Research & Technology van Pfizer Global Research & Development, eind 2006 een samenwerkingsinitiatief met de Wereldgezondheidsorganisatie.

Direction RDQ (Research, Development and Quality)
Directie RDQ (Research, Development and Quality)

les autorités publiques o l'INAMI, Service des Soins de Santé, Direction Research, Development & Quality
de overheid o RIZIV, Dienst Geneeskundige Verzorging, Directie Research, Development &

Le KCE, l’AIM, l’Institut scientifique de santé publique (ISSP), la Communauté française, la Communauté flamande et le Service Research, Development & Quality ( RDQ ) de l’INAMI y étaient également représentés.
Daarnaast waren ook het KCE, het IMA, het Wetenschappelijk Instituut Volksgezondheid (WIV), de Franse Gemeenschap, de Vlaamse Gemeenschap en de dienst Research, Development & Quality (RDQ) van het RIZIV vertegenwoordigd.